 | • レポートコード：MRC2305B121 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、232ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に6,908.51百万ドルであった世界の末梢神経修復デバイス市場規模が、2022年には7,870.39百万ドルに達し、2027年までに年平均14.10％成長して15,244.12百万ドルになると予測しています。当調査資料では、末梢神経修復デバイスの世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、デバイス別分析（生体材料、神経刺激＆ニューロモデュレーションデバイス）、用途別分析（直接神経修復/神経縫合術、神経移植、神経刺激＆ニューロモデュレーション手術、幹細胞療法）、エンドユーザー別分析（外来手術センター、病院＆クリニック）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目をまとめました。なお、当書に掲載されている企業情報には、Axogen Inc.、Baxter International、Boston Scientific Incorporation、Cyberonics Inc.、GlaxoSmithKline Pharmaceuticals Ltd.、Integra LifeSciences Corporation、Medovent GmbH、Medtronic PLC、NeuroMetrix, Inc.、Orthomed S.A.S.、Polyganics B.V.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の末梢神経修復デバイス市場規模：デバイス別 - 生体材料の市場規模 - 神経刺激＆ニューロモデュレーションデバイスの市場規模 ・世界の末梢神経修復デバイス市場規模：用途別 - 直接神経修復/神経縫合術における市場規模 - 神経移植における市場規模 - 神経刺激＆ニューロモデュレーション手術における市場規模 - 幹細胞療法における市場規模 ・世界の末梢神経修復デバイス市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 病院＆クリニックにおける市場規模 ・世界の末梢神経修復デバイス市場規模：地域別 - 南北アメリカの末梢神経修復デバイス市場規模 アメリカの末梢神経修復デバイス市場規模 カナダの末梢神経修復デバイス市場規模 ブラジルの末梢神経修復デバイス市場規模 ... - アジア太平洋の末梢神経修復デバイス市場規模 日本の末梢神経修復デバイス市場規模 中国の末梢神経修復デバイス市場規模 インドの末梢神経修復デバイス市場規模 韓国の末梢神経修復デバイス市場規模 台湾の末梢神経修復デバイス市場規模 ... - ヨーロッパ/中東/アフリカの末梢神経修復デバイス市場規模 イギリスの末梢神経修復デバイス市場規模 ドイツの末梢神経修復デバイス市場規模 フランスの末梢神経修復デバイス市場規模 ロシアの末梢神経修復デバイス市場規模 ... - その他地域の末梢神経修復デバイス市場規模 ・競争状況 ・企業情報 |
The Global Peripheral Nerve Repair Devices Market size was estimated at USD 6,908.51 million in 2021 and expected to reach USD 7,870.39 million in 2022, and is projected to grow at a CAGR 14.10% to reach USD 15,244.12 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Peripheral Nerve Repair Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Device, the market was studied across Biomaterial and Neurostimulation & Neuromodulation Device. The Biomaterial is further studied across Nerve Conduit, Nerve Connector, Nerve Protector, and Nerve Wrap. The Neurostimulation & Neuromodulation Device is further studied across External Neurostimulation Device and Internal Neurostimulation Device. The External Neurostimulation Device is further studied across Transcutaneous Electrical Nerve Stimulation and Transcutaneous Magnetic Stimulation. The Internal Neurostimulation Device is further studied across Deep Brain Stimulation, Gastric Electrical Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation.
Based on Application, the market was studied across Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgery, and Stem Cell Therapy. The Direct Nerve Repair/Neurorrhaphy is further studied across Epineural Repair, Group Fascicular Repair, and Perineural Repair. The Nerve Grafting is further studied across Allograft, Autograft, and Xenograft.
Based on End User, the market was studied across Ambulatory Surgery Center and Hospital & Clinic.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Peripheral Nerve Repair Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Peripheral Nerve Repair Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Peripheral Nerve Repair Devices Market, including Axogen Inc., Baxter International, Boston Scientific Incorporation, Cyberonics Inc., GlaxoSmithKline Pharmaceuticals Ltd., Integra LifeSciences Corporation, Medovent GmbH, Medtronic PLC, NeuroMetrix, Inc., Orthomed S.A.S., Polyganics B.V., Renerva, LLC,, St. Jude Medical, Stryker Corporation,, Synovis Micro Companies Alliance, Inc., and Toyobo Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Peripheral Nerve Repair Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Peripheral Nerve Repair Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Peripheral Nerve Repair Devices Market?
4. What is the competitive strategic window for opportunities in the Global Peripheral Nerve Repair Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Peripheral Nerve Repair Devices Market?
6. What is the market share of the leading vendors in the Global Peripheral Nerve Repair Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Peripheral Nerve Repair Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of nerve injury caused due to trauma, neurological syndrome, and accidents
5.1.1.2. Rising health awareness demanding surgical interventions
5.1.1.3. Growing adoption of advanced medical devices for the nerve repair treatment
5.1.2. Restraints
5.1.2.1. Potential health effect after functional recovery
5.1.3. Opportunities
5.1.3.1. Development of technology advanced nerve repair devices
5.1.3.2. Potential Asian countries due to presence of huge geriatric population coupled with the surge in the disposable income
5.1.4. Challenges
5.1.4.1. Development of cell-based therapies
5.2. Cumulative Impact of COVID-19
6. Peripheral Nerve Repair Devices Market, by Device
6.1. Introduction
6.2. Biomaterial
6.3.1. Nerve Conduit
6.3.2. Nerve Connector
6.3.3. Nerve Protector
6.3.4. Nerve Wrap
6.3. Neurostimulation & Neuromodulation Device
6.4.1. External Neurostimulation Device
6.4.2.1. Transcutaneous Electrical Nerve Stimulation
6.4.2.2. Transcutaneous Magnetic Stimulation
6.4.2. Internal Neurostimulation Device
6.4.3.1. Deep Brain Stimulation
6.4.3.2. Gastric Electrical Stimulation
6.4.3.3. Sacral Nerve Stimulation
6.4.3.4. Spinal Cord Stimulation
6.4.3.5. Vagus Nerve Stimulation
7. Peripheral Nerve Repair Devices Market, by Application
7.1. Introduction
7.2. Direct Nerve Repair/Neurorrhaphy
7.3.1. Epineural Repair
7.3.2. Group Fascicular Repair
7.3.3. Perineural Repair
7.3. Nerve Grafting
7.4.1. Allograft
7.4.2. Autograft
7.4.3. Xenograft
7.4. Neurostimulation & Neuromodulation Surgery
7.5. Stem Cell Therapy
8. Peripheral Nerve Repair Devices Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Center
8.3. Hospital & Clinic
9. Americas Peripheral Nerve Repair Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Peripheral Nerve Repair Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Peripheral Nerve Repair Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Axogen Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Baxter International
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Boston Scientific Incorporation
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Cyberonics Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. GlaxoSmithKline Pharmaceuticals Ltd.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Integra LifeSciences Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Medovent GmbH
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Medtronic PLC
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. NeuroMetrix, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Orthomed S.A.S.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Polyganics B.V.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Renerva, LLC,
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. St. Jude Medical
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Stryker Corporation,
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Synovis Micro Companies Alliance, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Toyobo Co., Ltd.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing